Summer Special! Get NewsNow Essentials at just £2.99 a month (25% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £2.99 a month (25% OFF!). Subscribe and saveSummer Special! Upgrade here at £2.99/m (25% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Novartis
Pharmaceuticals
GSK
Sanofi
AstraZeneca
Eli Lilly
Novo Nordisk
Johnson and Johnson
Merck and Co
Pfizer
Bristol Myers Squibb
Topics

Advertisement

Novartis

Share

Top Latest Popular

🌡️ HOT OFF THE PRESS! £2.99 a month for NewsNow Essentials. Upgrade here

🌡️ HOT OFF THE PRESS: NewsNow Essentials at just £2.99 a month. Faster, slicker, customisable & ad free. Upgrade here

Stat Plus: In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment STAT 1d

STAT 1d

3 Dividend stocks to buy for a lifetime of passive income The Motley Fool 18:34 Wed, 29 Jul

The Motley Fool 18:34 Wed, 29 Jul

Stock Watch: Why Novartis Stock Rose On Results Half As Good As J&J’s Scrip Pharma Intelligence 14:38 Tue, 28 Jul

Scrip Pharma Intelligence 14:38 Tue, 28 Jul

Advertisement

Attorney General Bonta Announces $400 Million Settlement in Principle with Sandoz, a Generic Drug Manufacturer, over Conspiracy to Inflate Prices and Limit Competition California Attorney General (Press Release) 8d

California Attorney General (Press Release) 8d

Advertisement

Natco challenges Novartis’s second patent for cancer drug ribociclib in Delhi High Court Mint 6d

Mint 6d

Cognizant bags IT operations deal from Novartis The Hindu Business Line 14:36 Tue, 28 Jul

The Hindu Business Line 14:36 Tue, 28 Jul

Advertisement

Advertisement

Latest

Earlier Today

AbbVie, Novartis Seek Block Illinois 340B Drug Discount Law Law360 02:09

Yesterday

AbbVie, Novartis Sue Illinois Over Hospital Drug Pharmacy Law Bloomberg Law 17:15 Mon, 10 Aug

Dr. Reddy’s, Novartis India terminate agreement The Hindu 16:56 Mon, 10 Aug

STAT Plus: In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment STAT 16:13 Mon, 10 Aug

Wednesday

Delhi HC seeks response on Natco's patent challenge plea The Economic Times 20:41 Wed, 05 Aug

Natco challenges Novartis’s second patent for cancer drug ribociclib in Delhi High Court Mint 12:31 Wed, 05 Aug

In the last month

AG Nessel Announces $400 Million Settlement in Principle with Sandoz Over Conspiracy to Inflate Prices and Limit Competition Michigan State Government (Press Release) 21:11 Mon, 03 Aug

Attorney General Bonta Announces $400 Million Settlement in Principle with Sandoz, a Generic Drug Manufacturer, over Conspiracy to Inflate Prices and Limit Competition California Attorney General (Press Release) 20:46 Mon, 03 Aug

Novartis’ Pluvicto approved by FDA for metastatic hormone-sensitive prostate cancer PMLiVE 13:20 Mon, 03 Aug

ChrysCapital acquires controlling 70.68% stake in Novartis' India listed unit in first majority pharma investment The Times of India 12:47 Thu, 30 Jul

Advertisement

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis